Tognoni, Gianni

Use of aspirin to reduce risk of initial vascular events in patients at moderate risk of cardiovascular disease (ARRIVE): a randomised, double-blind, placebo-controlled trial

Gaziano, J. M., Brotons, C., Coppolecchia, R., Cricelli, C., Darius, H., Gorelick, P. B., Howard, G., Pearson, T. A., Rothwell, P. M., Ruilope, L. M., et al. (2018) · The Lancet

Antiplatelet Therapy and Cardiovascular DiseasesLipoproteins and Cardiovascular Health

Cited by 883

Caffeine disposition after oral doses

Bonati, M., Latini, R., Galletti, F., Young, J. F., Tognoni, G., & Garattini, S. (1982) · Clinical Pharmacology and Therapeutics

Coffee research and impactsPharmacogenetics and Drug Metabolism

Cited by 353